05-Jan-16 Indonesia's largest pharmaceutical company, Kalbe Farma, is constructing a biopharmacy raw material manufacturing plant in Cikarang, West Java, scheduled to commence operations in late 2017 or 2018. State-controlled company Kimia Farma also announced recently that it would start constructing a INR100 bn (USD7 mn) raw materials plant in the same location. [image: Kalbe Farma and Kimia Farma]

29-Dec-15 Samsung Electronics is addressing growing demand for quantified health with an all-in-one chip for health wearables, called a Bio-Processor. Now in mass production, it is specially designed to accelerate development of innovative wearables for consumers who are increasingly monitoring their health. While heart rate alone may have been compelling in the past, measuring a variety of fitness data is now a must. [image: Business Korea]

27-Dec-15 Japanese health monitor maker Omron Healthcare is looking at more than doubling its revenues in India to USD40 mn by 2018/19, on the back of sales network expansion. The company, which is expecting sales of USD19 mn this year, is also open to the idea of opening a factory in India depending on the demand of its products. [image: Ormon Healthcare].

16-Dec-15 AstraZeneca aims to build up its already strong position in China by making and developing more medicines locally, and will invest more than USD800 mn in the country over the next 10 years. The British drugmaker's decision to step up investment, notably through a strategic alliance with WuXi AppTec, chimes with Beijing's desire to see more treatments made in China. [image: China Daily]

11-Dec-15 India’s Ministry of Health & Family Welfare (MOHFW) and the Central Drugs Standard Control Organization (CDSCO) have met with medical device association representatives to discuss how the country can become a hub for device manufacturing and begin to align with global regulations. The discussion centered on increasing device exports and evaluating new guidance for the industry. [image: RAPS]